. Lehman, Annexe 6. PLM scale (Paris-North, Lille and Montpellier Scale) (d'après, 2014.

M. Albert, S. Dekosky, D. Dickson, B. Dubois, H. Feldman et al., The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement, 2011.

S. Alladi, J. Xuereb, T. Bak, P. Nestor, J. Knibb et al., Focal cortical presentations of Alzheimer's disease. Brain, pp.2636-2681, 2007.

J. Alves, J. Soares, A. Sampaio, and O. Gonçalves, Posterior cortical atrophy and Alzheimer???s disease: a meta-analytic review of neuropsychological and brain morphometry studies, Brain Imaging and Behavior, vol.2012, issue.7, 2013.
DOI : 10.1007/s11682-013-9236-1

O. Andersen, J. Reiche, V. Schmidt, M. Gotthardt, R. Spoelgen et al., Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein, Proceedings of the National Academy of Sciences, vol.102, issue.38, pp.13461-13467, 2005.
DOI : 10.1073/pnas.0503689102

M. Armstrong, I. Litvan, A. Lang, T. Bak, K. Bhatia et al., Criteria for the diagnosis of corticobasal degeneration, Neurology, vol.80, issue.5, pp.496-503, 2013.
DOI : 10.1212/WNL.0b013e31827f0fd1

J. Attems, M. Quass, and K. Jellinger, Tau and ??-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs, Acta Neuropathologica, vol.60, issue.230, pp.53-62, 2007.
DOI : 10.1007/s00401-006-0146-9

M. Balasa, R. Sánchez-valle, A. Antonell, B. Bosch, J. Olives et al., Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment, J Alzheimers Dis, vol.40, issue.4, pp.919-946, 2014.

L. Bastard, N. Martin, J. Vanmechelen, E. Vanderstichele, H. et al., Added diagnostic value of CSF biomarkers in differential dementia diagnosis, Neurobiology of Aging, vol.31, issue.11, pp.1867-76, 2010.
DOI : 10.1016/j.neurobiolaging.2008.10.017

C. Bastin and E. Salmon, Early neuropsychological detection of Alzheimer's disease, European Journal of Clinical Nutrition, vol.38, issue.11, 2014.
DOI : 10.2174/156720511797633160

R. Bateman, C. Xiong, T. Benzinger, A. Fagan, A. Goate et al., Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease, New England Journal of Medicine, vol.367, issue.9, pp.795-804, 2012.
DOI : 10.1056/NEJMoa1202753

T. Benzinger, T. Blazey, C. Jack, . Jr, R. Koeppe et al., Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.110, issue.47, pp.4502-4511, 2013.
DOI : 10.1073/pnas.1317918110

G. Bloom, Amyloid-?? and Tau, JAMA Neurology, vol.71, issue.4, p.2014
DOI : 10.1001/jamaneurol.2013.5847

M. Bonner, S. Ash, and M. Grossman, The New Classification of Primary Progressive Aphasia into Semantic, Logopenic, or Nonfluent/Agrammatic Variants, Current Neurology and Neuroscience Reports, vol.68, issue.Pt 7, pp.484-90, 2010.
DOI : 10.1007/s11910-010-0140-4

B. Borroni, E. Premi, C. Agosti, A. Alberici, C. Cerini et al., CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.8, pp.834-842, 2011.
DOI : 10.1136/jnnp.2010.221853

F. Borruat, Posterior Cortical Atrophy: Review of the Recent Literature, Current Neurology and Neuroscience Reports, vol.55, issue.12, 2013.
DOI : 10.1007/s11910-013-0406-8

A. Brickman, K. Siedlecki, J. Muraskin, J. Manly, J. Luchsinger et al., White matter hyperintensities and cognition: Testing the reserve hypothesis, Neurobiology of Aging, vol.32, issue.9, pp.1588-98, 2011.
DOI : 10.1016/j.neurobiolaging.2009.10.013

J. Burns, J. Galvin, C. Roe, J. Morris, and D. Mckeel, The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs, Neurology, vol.64, issue.8, pp.1397-403, 2005.
DOI : 10.1212/01.WNL.0000158423.05224.7F

D. Boche and J. Nicoll, The role of the immune system in clearance of Abeta from the brain, Brain Pathol, 2008.

H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathologica, vol.80, issue.4, pp.239-259, 1991.
DOI : 10.1007/BF00308809

K. Brickell, E. Steinbart, M. Rumbaugh, H. Payami, G. Schellenberg et al., Early-Onset Alzheimer Disease in Families With Late-Onset Alzheimer Disease, Archives of Neurology, vol.63, issue.9, pp.1307-1318, 2006.
DOI : 10.1001/archneur.63.9.1307

H. Brunnström, N. Rawshani, H. Zetterberg, K. Blennow, L. Minthon et al., Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses, Alzheimer's & Dementia, vol.6, issue.2, 2010.
DOI : 10.1016/j.jalz.2009.12.005

J. Busciglio, D. Gabuzda, P. Matsudaira, and B. Yankner, Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells., Proceedings of the National Academy of Sciences, vol.90, issue.5, pp.2092-2098, 1993.
DOI : 10.1073/pnas.90.5.2092

D. Campion, C. Dumanchin, D. Hannequin, B. Dubois, S. Belliard et al., Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation Spectrum, The American Journal of Human Genetics, vol.65, issue.3, pp.664-670, 1999.
DOI : 10.1086/302553

G. Chételat, R. Ossenkoppele, V. Villemagne, A. Perrotin, B. Landeau et al., Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain, 2016.

X. Chen, M. Li, S. Wang, H. Zhu, Y. Xiong et al., Pittsburgh compound B retention and progression of cognitive status - a meta-analysis, European Journal of Neurology, vol.31, issue.8, pp.1060-1067, 2014.
DOI : 10.1111/ene.12398

J. Cockrell and M. Folstein, Mini-Mental State Examination (MMSE), Psychopharmacol Bull, vol.24, issue.4, pp.689-92, 1988.

S. Dekosky and S. Scheff, Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity, Annals of Neurology, vol.39, issue.5, pp.457-64, 1990.
DOI : 10.1002/ana.410270502

R. Cacace, K. Sleegers, and C. Van-broeckhoven, Molecular genetics of early-onset Alzheimer's disease revisited, Alzheimer's & Dementia, vol.12, issue.6
DOI : 10.1016/j.jalz.2016.01.012

J. Castellano, J. Kim, F. Stewart, H. Jiang, R. Demattos et al., Human apoE Isoforms Differentially Regulate Brain Amyloid-?? Peptide Clearance, Science Translational Medicine, vol.3, issue.89, pp.89-57, 2011.
DOI : 10.1126/scitranslmed.3002156

J. K. Cataldo, J. J. Prochaska, and S. A. Glantz, Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation, J. Alzheimers Dis. JAD, vol.19, pp.465-480, 2010.

D. Cheng, J. Noble, M. X. Tang, N. Schupf, R. Mayeux et al., Type 2 Diabetes and Late-Onset Alzheimer???s Disease, Dementia and Geriatric Cognitive Disorders, vol.31, issue.6, pp.424-430, 2011.
DOI : 10.1159/000324134

C. Cordonnier, W. Van-der-flier, J. Sluimer, D. Leys, F. Barkhof et al., Prevalence and severity of microbleeds in a memory clinic setting, Neurology, vol.66, issue.9, pp.1356-60, 2006.
DOI : 10.1212/01.wnl.0000210535.20297.ae

S. Crutch, M. Lehmann, J. Schott, G. Rabinovici, M. Rossor et al., Posterior cortical atrophy, The Lancet Neurology, vol.11, issue.2, pp.170-178
DOI : 10.1016/S1474-4422(11)70289-7

URL : https://hal.archives-ouvertes.fr/hal-01289466

M. Cuccaro, R. Carney, Y. Zhang, C. Bohm, B. Kunkle et al., Pathogenic SORL1 mutations andparkinsonian features in Alzheimer's disease. AAIC P1-226, 2016.

D. Mesquita, S. Ferreira, A. Sousa, J. Correia-neves, M. Sousa et al., Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system, Neuroscience & Biobehavioral Reviews, vol.68, pp.547-562, 2016.
DOI : 10.1016/j.neubiorev.2016.06.014

M. Dejesus-hernandez, I. Mackenzie, B. Boeve, A. Boxer, M. Baker et al., Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, pp.245-56, 2011.

V. Deramecourt, F. Lebert, B. Debachy, M. Mackowiak-cordoliani, S. Bombois et al., Prediction of pathology in primary progressive language and speech disorders, Neurology, vol.74, issue.1, pp.42-51, 2010.
DOI : 10.1212/WNL.0b013e3181c7198e

C. Derby, L. Burns, C. Wang, M. Katz, and M. Zimmerman, Screening for predementia AD: Time-dependent operating characteristics of episodic memory tests, Neurology, vol.80, issue.14, pp.1307-1321, 2013.
DOI : 10.1212/WNL.0b013e31828ab2c9

D. Fede, G. Catania, M. Morbin, M. Giaccone, G. Moro et al., Good gene, bad gene: New APP variant may be both, Progress in Neurobiology, vol.99, issue.3, pp.281-92, 2012.
DOI : 10.1016/j.pneurobio.2012.06.004

S. Dodson, O. Andersen, V. Karmali, J. Fritz, D. Cheng et al., Loss of LR11/SORLA Enhances Early Pathology in a Mouse Model of Amyloidosis: Evidence for a Proximal Role in Alzheimer's Disease, Journal of Neuroscience, vol.28, issue.48, pp.12877-86, 2008.
DOI : 10.1523/JNEUROSCI.4582-08.2008

R. Duara, D. Loewenstein, Q. Shen, W. Barker, D. Varon et al., The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects, Frontiers in Aging Neuroscience, vol.5, p.47, 2013.
DOI : 10.3389/fnagi.2013.00047

B. Dubois, J. Touchon, F. Portet, P. J. Ousset, B. Vellas et al., The 5 words " : a simple and sensitive test for the diagnosis of Alzheimer's disease]. Presse Médicale Paris Fr, pp.31-1696, 1983.

B. Dubois, H. Feldman, C. Jacova, H. Hampel, J. Molinuevo et al., Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, The Lancet Neurology, vol.13, issue.6, pp.614-643
DOI : 10.1016/S1474-4422(14)70090-0

F. Duits, C. Teunissen, F. Bouwman, P. Visser, N. Mattsson et al., The cerebrospinal fluidAlzheimer profile": easily said, but what does it mean? Alzheimers Dement, pp.713-723, 2014.

C. Dumanchin, A. Brice, D. Campion, D. Hannequin, C. Martin et al., De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group., Journal of Medical Genetics, vol.35, issue.8, pp.672-675, 1998.
DOI : 10.1136/jmg.35.8.672

S. Dumanis, T. Burgert, S. Caglayan, A. Füchtbauer, E. Füchtbauer et al., Distinct Functions for Anterograde and Retrograde Sorting of SORLA in Amyloidogenic Processes in the Brain, Journal of Neuroscience, vol.35, issue.37, pp.12703-12716, 2015.
DOI : 10.1523/JNEUROSCI.0427-15.2015

C. Duyckaerts, B. Delatour, and M. Potier, Classification and basic pathology of Alzheimer disease, Acta Neuropathologica, vol.14, issue.2, pp.5-36, 2009.
DOI : 10.1007/s00401-009-0532-1

S. Engelborghs, D. Vreese, K. Van-de-casteele, T. Vanderstichele, H. Van-everbroeck et al., Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia, Neurobiology of Aging, vol.29, issue.8, pp.1143-59, 2008.
DOI : 10.1016/j.neurobiolaging.2007.02.016

P. Eikelenboom, R. Veerhuis, A. Familian, J. Hoozemans, W. Van-gool et al., Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications, Neurodegener Dis, vol.5, pp.3-4190, 2008.

C. D. Etherton-beer, Vascular cognitive impairment in dementia, Maturitas, vol.79, issue.2, pp.220-226, 2014.
DOI : 10.1016/j.maturitas.2014.06.004

L. Farrer, L. Cupples, J. Haines, B. Hyman, W. Kukull et al., Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium, JAMA: The Journal of the American Medical Association, vol.278, issue.16, pp.1349-56, 1997.
DOI : 10.1001/jama.278.16.1349

W. Forbes and G. Hill, Is Exposure to Aluminum a Risk Factor for the Development of Alzheimer Disease????Yes, Archives of Neurology, vol.55, issue.5, pp.740-741, 1998.
DOI : 10.1001/archneur.55.5.740

D. Friedman, L. Honig, and N. Scarmeas, Seizures and Epilepsy in Alzheimer's Disease, CNS Neuroscience & Therapeutics, vol.21, issue.Suppl 1, 2012.
DOI : 10.1111/j.1755-5949.2011.00251.x

G. Frisoni, S. Galluzzi, L. Pantoni, and M. Filippi, The effect of white matter lesions on cognition in the elderly???small but detectable, Nature Clinical Practice Neurology, vol.33, issue.11, pp.620-627, 2007.
DOI : 10.1038/ncpneuro0638

C. Gallez, Rapport sur la maladie d'Alzheimer et les maladies apparentées. Paris : Office parlementaire d'évaluation des politiques de santé, 2005.

J. Garre-olmo, G. Batlle, D. Del-mar-fernández, M. , M. Daniel et al., Incidence and subtypes of early-onset dementia in a geographically defined general population, Neurology, vol.75, issue.14, pp.1249-55, 2010.
DOI : 10.1212/WNL.0b013e3181f5d4c4

E. Genin, D. Hannequin, D. Wallon, K. Sleegers, M. Hiltunen et al., APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry, pp.903-910, 2011.

G. Glenner and C. Wong, Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochemical and Biophysical Research Communications, vol.120, issue.3, pp.534-543, 1984.
DOI : 10.1016/S0006-291X(84)80190-4

M. Golan, M. Styczy?ska, K. Jó?wiak, J. Walecki, A. Maruszak et al., Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene, Experimental Neurology, vol.208, issue.2, pp.264-272, 2007.
DOI : 10.1016/j.expneurol.2007.08.016

M. Gorno-tempini, N. Dronkers, K. Rankin, J. Ogar, L. Phengrasamy et al., Cognition and anatomy in three variants of primary progressive aphasia, Annals of Neurology, vol.60, issue.3, pp.335-381, 2004.
DOI : 10.1002/ana.10825

M. Gorno-tempini, A. Hillis, S. Weintraub, A. Kertesz, M. Mendez et al., Classification of primary progressive aphasia and its variants, Neurology, vol.76, issue.11, pp.1006-1020, 2011.
DOI : 10.1212/WNL.0b013e31821103e6

E. Grober, H. Buschke, H. Crystal, S. Bang, and R. Dresner, Screening for dementia by memory testing, Neurology, vol.38, issue.6, pp.900-903, 1988.
DOI : 10.1212/WNL.38.6.900

A. Grudzien, P. Shaw, S. Weintraub, E. Bigio, D. Mash et al., Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease, Neurobiology of Aging, vol.28, issue.3, 2007.
DOI : 10.1016/j.neurobiolaging.2006.02.007

R. Guerreiro, M. Baquero, R. Blesa, M. Boada, J. Brás et al., Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP, Neurobiology of Aging, vol.31, issue.5, 2010.
DOI : 10.1016/j.neurobiolaging.2008.06.012

R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva et al., Variants in Alzheimer's Disease, New England Journal of Medicine, vol.368, issue.2, pp.117-144, 2013.
DOI : 10.1056/NEJMoa1211851

A. Güntert, H. Döbeli, and B. Bohrmann, High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain, Neuroscience, vol.143, issue.2, pp.461-75, 2006.
DOI : 10.1016/j.neuroscience.2006.08.027

I. Guyant-marechal, E. Berger, A. Laquerrière, A. Rovelet-lecrux, G. Viennet et al., INTRAFAMILIAL DIVERSITY OF PHENOTYPE ASSOCIATED WITH APP DUPLICATION, Neurology, vol.71, issue.23, pp.1925-1931, 2008.
DOI : 10.1212/01.wnl.0000339400.64213.56

URL : https://hal.archives-ouvertes.fr/hal-00482227

C. Haass, M. Schlossmacher, A. Hung, C. Vigo-pelfrey, A. Mellon et al., Amyloid ??-peptide is produced by cultured cells during normal metabolism, Nature, vol.359, issue.6393, pp.322-327, 1992.
DOI : 10.1038/359322a0

C. Haass and D. Selkoe, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid ??-peptide, Nature Reviews Molecular Cell Biology, vol.26, issue.2, pp.101-113, 2007.
DOI : 10.1038/nrm2101

O. Hansson, H. Zetterberg, P. Buchhave, E. Londos, K. Blennow et al., Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study, The Lancet Neurology, vol.5, issue.3, pp.228-34293, 2006.
DOI : 10.1016/S1474-4422(06)70355-6

J. Hardy, The Alzheimer family of diseases: Many etiologies, one pathogenesis?, Proceedings of the National Academy of Sciences, vol.94, issue.6, pp.2095-2102, 1997.
DOI : 10.1073/pnas.94.6.2095

R. Harvey, M. Skelton-robinson, and M. Rossor, The prevalence and causes of dementia in people under the age of 65 years, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.9, pp.1206-1215, 2003.
DOI : 10.1136/jnnp.74.9.1206

A. Hassan, J. Whitwell, and K. Josephs, The corticobasal syndrome???Alzheimer???s disease conundrum, Expert Review of Neurotherapeutics, vol.11, issue.11, pp.1569-78, 2011.
DOI : 10.1586/ern.11.153

W. Hu, G. Rippon, B. Boeve, D. Knopman, R. Petersen et al., Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome, Movement Disorders, vol.68, issue.Part 10, pp.1375-1384, 2009.
DOI : 10.1002/mds.22574

M. Irizarry, J. S. He, F. Emond, J. Raman, R. Thomas et al., Incidence of New-Onset Seizures in Mild to Moderate Alzheimer Disease, Archives of Neurology, vol.69, issue.3, pp.368-372, 2012.
DOI : 10.1001/archneurol.2011.830

C. Jack, . Jr, D. Knopman, G. Chételat, D. Dickson et al., Suspected non-Alzheimer disease pathophysiology ??? concept and controversy, Nature Reviews Neurology, vol.33, issue.2, pp.117-141, 2016.
DOI : 10.1038/nrneurol.2015.251

J. Johnson, E. Head, R. Kim, A. Starr, and C. Cotman, Clinical and Pathological Evidence for a Frontal Variant of Alzheimer Disease, Archives of Neurology, vol.56, issue.10, pp.1233-1242, 1999.
DOI : 10.1001/archneur.56.10.1233

T. Jonsson, J. Atwal, S. Steinberg, J. Snaedal, P. Jonsson et al., A mutation in APP protects against Alzheimer???s disease and age-related cognitive decline, Nature, vol.43, issue.7409, pp.96-105, 2012.
DOI : 10.1038/nature11283

T. Jonsson, H. Stefansson, S. Steinberg, I. Jonsdottir, P. Jonsson et al., Associated with the Risk of Alzheimer's Disease, New England Journal of Medicine, vol.368, issue.2, pp.107-123, 2013.
DOI : 10.1056/NEJMoa1211103

B. Jost and G. Grossberg, The Natural History of Alzheimer's Disease: A Brain Bank Study, Journal of the American Geriatrics Society, vol.51, issue.suppl l, 1995.
DOI : 10.1111/j.1532-5415.1995.tb07401.x

H. Karlstrom, W. Brooks, J. Kwok, G. Broe, J. Kril et al., Variable phenotype of Alzheimer's disease with spastic paraparesis, J Neurochem. Feb, vol.104, issue.3, pp.573-83, 2008.

W. Klunk, Amyloid imaging as a biomarker for cerebral ??-amyloidosis and risk prediction for Alzheimer dementia, Neurobiology of Aging, vol.32, issue.1, pp.20-36, 2011.
DOI : 10.1016/j.neurobiolaging.2011.09.006

D. Knopman, S. Dekosky, J. Cummings, H. Chui, J. Corey-bloom et al., Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, vol.56, issue.9, pp.1143-53, 2001.
DOI : 10.1212/WNL.56.9.1143

E. Koedam, V. Lauffer, A. Van-der-vlies, W. Van-der-flier, P. Scheltens et al., Early-versus late-onset Alzheimer's disease: more than age alone, J Alzheimers Dis, vol.19, issue.4, pp.1401-1409, 2010.

M. Lambert, H. Bickel, M. Prince, L. Fratiglioni, V. Strauss et al., Estimating the burden of early onset dementia; systematic review of disease prevalence, European Journal of Neurology, vol.40, issue.Pt 9, pp.563-572
DOI : 10.1111/ene.12325

A. Larner and M. Doran, Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update, J Alzheimers Dis, vol.17, issue.2, pp.259-65, 2009.

A. Larner, Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships, J Alzheimers Dis, vol.37, issue.4, pp.653-662, 2013.

S. Lehmann, J. Dumurgier, S. Schraen, D. Wallon, F. Blanc et al., A diagnostic scale for Alzheimer???s disease based on cerebrospinal fluid biomarker profiles, Alzheimer's Research & Therapy, vol.6, issue.3, p.38, 2014.
DOI : 10.1186/alzrt267

S. Lehmann, S. Schraen, I. Quadrio, C. Paquet, S. Bombois et al., Impact of harmonization of collection tubes on Alzheimer's disease diagnosis, Alzheimer's & Dementia, vol.10, issue.5, pp.390-394, 2014.
DOI : 10.1016/j.jalz.2013.06.008

E. Masliah, M. Mallory, M. Alford, R. Deteresa, L. Hansen et al., Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease, Neurology, vol.56, issue.1, pp.127-136, 2001.
DOI : 10.1212/WNL.56.1.127

R. Mathew, T. Bak, and J. Hodges, Diagnostic criteria for corticobasal syndrome: a comparative study, Journal of Neurology, Neurosurgery & Psychiatry, vol.83, issue.4, pp.405-415
DOI : 10.1136/jnnp-2011-300875

J. Matías-guiu, M. Cabrera-martín, T. Moreno-ramos, M. Valles-salgado, M. Fernandez-matarrubia et al., Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes, Journal of Neurology, vol.84, issue.6, pp.1463-72
DOI : 10.1007/s00415-015-7738-z

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, issue.7, pp.939-983, 1984.
DOI : 10.1212/WNL.34.7.939

G. Mckhann, D. Knopman, H. Chertkow, B. Hyman, C. Jack et al., Et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, pp.263-272, 2011.

P. Mcmonagle, F. Deering, Y. Berliner, and A. Kertesz, The cognitive profile of posterior cortical atrophy, Neurology Feb, vol.1466, issue.3, pp.331-339, 2006.

M. Mesulam, S. Weintraub, E. Rogalski, C. Wieneke, C. Geula et al., Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia, Brain, vol.137, issue.4, pp.1176-92
DOI : 10.1093/brain/awu024

P. Mistridis, S. Krumm, A. Monsch, M. Berres, and K. Taylor, The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer???s Disease: The Temporal Emergence of Cognitive Decline, Journal of Alzheimer's Disease, vol.48, issue.4, pp.1095-107, 2015.
DOI : 10.3233/JAD-150137

L. Mosconi, Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease, European Journal of Nuclear Medicine and Molecular Imaging, vol.11, issue.Suppl 2, pp.486-510, 2005.
DOI : 10.1007/s00259-005-1762-7

P. Nestor, D. Caine, T. Fryer, C. J. Hodges, and J. , The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.11, 2003.
DOI : 10.1136/jnnp.74.11.1521

G. Nicolas, D. Wallon, C. Charbonnier, O. Quenez, S. Rousseau et al., Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons, European Journal of Human Genetics, vol.39, issue.5, pp.710-716, 2016.
DOI : 10.1007/s00415-013-7160-3

URL : https://hal.archives-ouvertes.fr/hal-01431285

G. Nicolas, C. Charbonnier, D. Wallon, O. Quenez, C. Bellenguez et al., CNR-MAJ collaborators. SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's disease. Mol Psychiatry, pp.831-837, 2016.

R. Ossenkoppele, Y. Pijnenburg, D. Perry, B. Cohn-sheehy, N. Scheltens et al., The behavioural/dysexecutive variant of Alzheimer???s disease: clinical, neuroimaging and pathological features, Brain, vol.138, issue.9, pp.2732-2781, 2015.
DOI : 10.1093/brain/awv191

R. Ossenkoppele, B. Cohn-sheehy, L. Joie, R. Vogel, J. Möller et al., Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Hum Brain Mapp, pp.4421-4458, 2015.

D. Pandis and N. Scarmeas, Seizures in Alzheimer disease: clinical and epidemiological data. Epilepsy Curr, 2012.

A. Perret-liaudet, M. Pelpel, Y. Tholance, B. Dumont, H. Vanderstichele et al., Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes, J Alzheimers Dis, vol.31, issue.1, pp.13-20, 2012.

G. Perry, M. Kawai, M. Tabaton, M. Onorato, P. Mulvihill et al., Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton, J Neurosci, vol.11, issue.6, pp.1748-55, 1991.

L. Pini, M. Pievani, M. Bocchetta, D. Altomare, P. Bosco et al., Brain atrophy in Alzheimer???s Disease and aging, Ageing Research Reviews, vol.30, issue.16, pp.1568-163730002, 2016.
DOI : 10.1016/j.arr.2016.01.002

C. Pottier, D. Wallon, A. Lecrux, D. Maltete, S. Bombois et al., Amyloid-? protein precursor gene expression in alzheimer's disease and other conditions, J Alzheimers Dis, vol.28, pp.561-566, 2012.

C. Pottier, D. Hannequin, S. Coutant, A. Rovelet-lecrux, D. Wallon et al., High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease, Molecular Psychiatry, vol.17, issue.9, pp.875-884, 2012.
DOI : 10.1093/hmg/ddq390

URL : https://hal.archives-ouvertes.fr/hal-00965204

H. Querfurth and F. Laferla, Alzheimer's Disease, New England Journal of Medicine, vol.362, issue.4, pp.329-373, 2010.
DOI : 10.1056/NEJMra0909142

H. Quigley, S. Colloby, O. Brien, and J. , PET imaging of brain amyloid in dementia: a review, International Journal of Geriatric Psychiatry, vol.46, issue.(Suppl 2), pp.991-1000, 2011.
DOI : 10.1002/gps.2640

C. Reitz, R. Cheng, E. Rogaeva, J. Lee, S. Tokuhiro et al., Meta-analysis of the Association Between Variants in SORL1 and Alzheimer Disease, Archives of Neurology, vol.68, issue.1, pp.99-106, 2011.
DOI : 10.1001/archneurol.2010.346

J. Renner, J. Burns, C. Hou, D. Mckeel, . Jr et al., Progressive posterior cortical dysfunction: A clinicopathologic series, Neurology, vol.63, issue.7, pp.1175-80, 2004.
DOI : 10.1212/01.WNL.0000140290.80962.BF

E. Rogaeva, Y. Meng, J. Lee, Y. Gu, T. Kawarai et al., The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease, Nature Genetics, vol.279, issue.2, pp.168-77, 2007.
DOI : 10.1038/ng1943

E. Rogalski, S. Weintraub, and M. Mesulam, Are there susceptibility factors for primary progressive aphasia? Brain Lang, pp.135-143, 2013.

G. Román, T. Tatemichi, T. Erkinjuntti, J. Cummings, J. Masdeu et al., Vascular dementia: diagnostic criteria for research studies, 1993.

R. Rosenberg, D. Lambracht-washington, G. Yu, and W. Xia, Genomics of Alzheimer Disease, JAMA Neurology, vol.73, issue.7, pp.867-74, 2016.
DOI : 10.1001/jamaneurol.2016.0301

S. Rountree, W. Chan, V. Pavlik, E. Darby, and R. Doody, Factors that influence survival in a probable Alzheimer disease cohort, Alzheimer's Research & Therapy, vol.4, issue.3, p.16, 2012.
DOI : 10.1186/alzrt119

A. Rovelet-lecrux, D. Hannequin, G. Raux, L. Meur, N. Laquerrière et al., APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy, Nature Genetics, vol.302, issue.1, 2006.
DOI : 10.1038/ng1718

A. Rovelet-lecrux, C. Charbonnier, D. Wallon, N. G. Seaman, M. Pottier et al., De novo deleterious genetic variations target a biological network centered on A?? peptide in early-onset Alzheimer disease, Molecular Psychiatry, vol.42, issue.9, pp.1046-56, 2015.
DOI : 10.1038/mp.2015.100

M. Sarazin, C. Berr, D. Rotrou, J. Fabrigoule, C. Pasquier et al., Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study, Neurology, vol.69, issue.19, pp.1859-67, 2007.
DOI : 10.1212/01.wnl.0000279336.36610.f7

URL : https://hal.archives-ouvertes.fr/inserm-00169640

M. Sarazin, V. Chauviré, E. Gerardin, O. Colliot, S. Kinkingnéhun et al., The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study, J Alzheimers Dis, vol.22, issue.1, pp.285-94, 2010.

I. Sassin, C. Schultz, D. Thal, U. Rüb, K. Arai et al., Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert, Acta Neuropathologica, vol.100, issue.3, pp.259-69, 2000.
DOI : 10.1007/s004019900178

N. Scarmeas, J. Brandt, M. Albert, G. Hadjigeorgiou, A. Papadimitriou et al., Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease, Archives of Neurology, vol.62, issue.10, pp.1601-1609, 2005.
DOI : 10.1001/archneur.62.10.1601

N. Scarmeas, L. Honig, H. Choi, J. Cantero, J. Brandt et al., Seizures in Alzheimer Disease, Archives of Neurology, vol.66, issue.8, pp.992-999, 2009.
DOI : 10.1001/archneurol.2009.130

S. Scheff and D. Price, Synapse loss in the temporal lobe in Alzheimer's disease, Annals of Neurology, vol.192, issue.2, pp.190-199, 1993.
DOI : 10.1002/ana.410330209

S. Scheff and D. Price, Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus, J Alzheimers Dis, vol.9, issue.3, pp.101-116, 2006.

N. Scheltens, F. Galindo-garre, Y. Pijnenburg, A. Van-der-vlies, L. Smits et al., The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis, Journal of Neurology, Neurosurgery & Psychiatry, vol.39, issue.(19 Pt 2), pp.235-278, 2016.
DOI : 10.1136/jnnp-2014-309582

H. Schipper, Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment, Neurobiology of Aging, vol.32, issue.5, pp.778-90, 2011.
DOI : 10.1016/j.neurobiolaging.2009.04.021

D. Selkoe, Amyloid ??-protein precursor: new clues to the genesis of Alzheimer's disease, Current Opinion in Neurobiology, vol.4, issue.5, pp.708-724, 1994.
DOI : 10.1016/0959-4388(94)90014-0

T. Seppälä, O. Nerg, A. Koivisto, J. Rummukainen, L. Puli et al., CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings, Neurology, vol.78, issue.20, pp.1568-75, 2012.
DOI : 10.1212/WNL.0b013e3182563bd0

R. Sherrington, S. Froelich, S. Sorbi, D. Campion, C. H. Rogaeva et al., Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant, Human Molecular Genetics, vol.5, issue.7, pp.985-993, 1996.
DOI : 10.1093/hmg/5.7.985

D. Silverman, G. Small, C. Chang, C. Lu, M. Kung-de-aburto et al., Positron Emission Tomography in Evaluation of Dementia, JAMA, vol.286, issue.17, 2001.
DOI : 10.1001/jama.286.17.2120

G. ?imi?, B. Leko, M. Wray, S. Harrington, C. Delalle et al., Monoaminergic neuropathology in Alzheimer's disease. Prog Neurobiol, 2016.

T. Skillbäck, B. Farahmand, C. Rosén, N. Mattsson, K. Nägga et al., in patients with dementia, Brain, vol.138, issue.9, pp.2716-2747, 2015.
DOI : 10.1093/brain/awv181

L. Smits, Y. Pijnenburg, E. Koedam, A. Van-der-vlies, I. Reuling et al., Early-onset Alzheimer's disease is associated with a distinct neuropsychological profile, Alzheimer's & Dementia, vol.7, issue.4, pp.101-109, 2012.
DOI : 10.1016/j.jalz.2011.05.760

L. Souza, F. Corlier, M. Habert, O. Uspenskaya, R. Maroy et al., Similar amyloid-?? burden in posterior cortical atrophy and Alzheimer's disease, Brain, vol.134, issue.7, pp.2036-2079, 2011.
DOI : 10.1093/brain/awr130

L. Souza, F. Lamari, S. Belliard, C. Jardel, C. Houillier et al., Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.3, 2011.
DOI : 10.1136/jnnp.2010.207183

L. Souza, M. Chupin, F. Lamari, C. Jardel, D. Leclercq et al., CSF tau markers are correlated with hippocampal volume in Alzheimer's disease, Neurobiology of Aging, vol.33, issue.7, pp.1253-1260
DOI : 10.1016/j.neurobiolaging.2011.02.022

D. Spackman, S. Kadiyala, P. Neumann, D. Veenstra, and S. Sullivan, Measuring Alzheimer Disease Progression with Transition Probabilities: Estimates from NACC-UDS, Current Alzheimer Research, vol.9, issue.9, pp.1050-1058
DOI : 10.2174/156720512803569046

D. Stefano, F. Kas, A. Habert, M. Decazes, P. Lamari et al., The phenotypical core of Alzheimer-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging,and biomarker study. Alzheimers Dement, pp.786-95786, 2016.

Y. Stern, Cognitive reserve in ageing and Alzheimer's disease, The Lancet Neurology, vol.11, issue.11, pp.1006-1018, 2012.
DOI : 10.1016/S1474-4422(12)70191-6

C. Stopford, J. Snowden, J. Thompson, and D. Neary, Variability in cognitive presentation of Alzheimer's disease. Cortex, Feb, vol.44, issue.2, pp.185-95, 2008.

F. Tabaraud, J. Leman, A. Milor, J. Roussie, G. Barrière et al., Alzheimer CSF biomarkers in routine clinical setting, Acta Neurologica Scandinavica, vol.74, issue.6, pp.416-439
DOI : 10.1111/j.1600-0404.2011.01592.x

D. Tang-wai, N. Graff-radford, B. Boeve, D. Dickson, J. Parisi et al., Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy, Neurology, vol.63, issue.7, pp.1168-74, 2004.
DOI : 10.1212/01.WNL.0000140289.18472.15

T. Tapiola, I. Alafuzoff, S. Herukka, L. Parkkinen, P. Hartikainen et al., Cerebrospinal fluid {beta}amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain, Arch Neurol, vol.66, issue.3, pp.382-391, 2009.

R. Terry, E. Masliah, D. Salmon, N. Butters, R. Deteresa et al., Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment, Annals of Neurology, vol.3, issue.4, pp.572-80, 1991.
DOI : 10.1002/ana.410300410

D. Thal, U. Rüb, M. Orantes, and H. Braak, Phases of A??-deposition in the human brain and its relevance for the development of AD, Neurology, vol.58, issue.12, pp.1791-800, 2002.
DOI : 10.1212/WNL.58.12.1791

M. Teichmann, A. Kas, C. Boutet, S. Ferrieux, M. Nogues et al., Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation, Brain, vol.136, issue.11, pp.3474-88, 2013.
DOI : 10.1093/brain/awt266

URL : https://hal.archives-ouvertes.fr/hal-00938644

S. Thordardottir, A. Ståhlbom, D. Ferreira, O. Almkvist, E. Westman et al., Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease, J Alzheimers Dis, vol.43, issue.4, pp.1393-402, 2015.

L. De-toledo-morrell, I. Goncharova, B. Dickerson, R. Wilson, and D. Bennett, From Healthy Aging to Early Alzheimer's Disease: In Vivo Detection of Entorhinal Cortex Atrophy, Annals of the New York Academy of Sciences, vol.10, issue.1, pp.240-53, 2000.
DOI : 10.1111/j.1749-6632.2000.tb06730.x

M. Tsolaki, K. Kokarida, V. Iakovidou, E. Stilopoulos, J. Meimaris et al., Extrapyramidal symptoms and signs in Alzheimer's disease: Pravalence and correlation with the first symptom, American Journal of Alzheimer's Disease and Other Dementias, vol.16, issue.5, pp.268-78, 2001.
DOI : 10.1177/153331750101600512

J. Verheijen, T. Van-den-bossche, J. Van-der-zee, S. Engelborghs, R. Sanchez-valle et al., A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer???s disease, Acta Neuropathologica, vol.16, issue.2005, pp.213-237, 2016.
DOI : 10.1016/j.stem.2015.02.004

A. Villarejo, J. Benito-león, R. Trincado, I. Posada, V. Puertas-martín et al., Dementia-associated mortality at thirteen years in the NEDICES Cohort Study, J Alzheimers Dis, vol.26, issue.3, pp.543-51, 2011.

P. Visser, F. Verhey, D. Knol, P. Scheltens, L. Wahlund et al., Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study, The Lancet Neurology, vol.8, issue.7, pp.619-646, 2009.
DOI : 10.1016/S1474-4422(09)70139-5

M. Wagner, S. Wolf, F. Reischies, M. Daerr, S. Wolfsgruber et al., Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease, Neurology, vol.78, issue.6, pp.379-86, 2012.
DOI : 10.1212/WNL.0b013e318245f447

D. Wallon, S. Rousseau, A. Rovelet-lecrux, M. Quillard-muraine, L. Guyant-maréchal et al., collaborators of GMAJ project. The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers, J Alzheimers Dis, vol.30, issue.4, pp.847-56, 2012.

D. Wallon, A. Rovelet-lecrux, V. Deramecourt, J. Pariente, S. Auriacombe et al., Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers, J Alzheimers Dis, vol.32, issue.1, pp.19-22, 2012.

R. A. Whitmer, S. Sidney, J. Selby, S. C. Johnston, Y. et al., Midlife cardiovascular risk factors and risk of dementia in late life, Neurology, vol.64, issue.2, pp.277-281, 2005.
DOI : 10.1212/01.WNL.0000149519.47454.F2

J. Whitwell, C. Jack, . Jr, K. Kantarci, S. Weigand et al., Imaging correlates of posterior cortical atrophy, Neurobiology of Aging, vol.28, issue.7, pp.1051-61, 2007.
DOI : 10.1016/j.neurobiolaging.2006.05.026

M. Wolfe, When loss is gain: reduced presenilin proteolytic function leads to increased A??42/A??40. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO reports, vol.2, issue.2, pp.136-176, 2007.
DOI : 10.1038/sj.embor.7400896

J. Xie, C. Brayne, and F. Matthews, Medical Research Council Cognitive Function and Ageing Study collaborators. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up

W. Yau, D. Tudorascu, E. Mcdade, S. Ikonomovic, J. James et al., Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study, The Lancet Neurology, vol.14, issue.8, pp.804-817, 2015.
DOI : 10.1016/S1474-4422(15)00135-0